US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class III · Low risk Terminated

Dots Scented Antibacterial Hand Gel Orange

Reason CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.

NingBo Huize Commodity Co.,Ltd. D-1538-2019
Class III · Low risk Terminated

Good to Go Hand Sanitizer

Reason CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.

NingBo Huize Commodity Co.,Ltd. D-1530-2019
Class III · Low risk Terminated

Telmisartan and Amlodipine Tablets 80 mg/5 mg

Reason Failed Impurities/Degradation Specifications; 18 month long term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-198-06 D-1121-2019
Class III · Low risk Terminated

Clonidine HCL Injection

Reason Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.

X-Gen Pharmaceuticals Inc. NDC 39822-2000-1 D-1084-2019
Class II · Moderate risk Terminated

Pantoprazole Sodium Delayed-Release Tablets

Reason Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-284-90 D-1074-2019
Class I · High risk Terminated

Lidocaine HCl Injection

Reason Presence of Particulate Matter: One vial was found to contain a hair.

Aurobindo Pharma USA Inc. NDC 55150-162-05 D-1248-2019
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Akorn, Inc. NDC 50383-587-16 D-1080-2019
Class III · Low risk Terminated

Thallous Chloride TI 201 Injection

Reason Chemical Contamination: Trace amounts of an impurity was detected in the reagent used to manufacture finished product.

Medi-Physics Inc. dba GE Healthcare D-1134-2019
Class II · Moderate risk Terminated

Phenobarbital Oral Solution

Reason Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Lohxa LLC NDC 70166-536-02 D-1131-2019
Class II · Moderate risk Terminated

Bismuth Subsalicylate Oral Suspension 262mg/15mL

Reason Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Lohxa LLC NDC 70166-059-01 D-1130-2019
Class II · Moderate risk Terminated

Pravastatin Sodium Tablets USP

Reason Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.

Glenmark Pharmaceuticals Inc., USA NDC 68462-196-05 D-1120-2019
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter.

InvaGen Pharmaceuticals, Inc. NDC 69097-536-37 D-1125-2019
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter.

InvaGen Pharmaceuticals, Inc. NDC 69097-537-31 D-1124-2019
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter.

InvaGen Pharmaceuticals, Inc. NDC 69097-537-37 D-1123-2019
Class III · Low risk Terminated

Biotin 10 mg/mL Injection

Reason Failed pH Specification: product does not meet pH label claim.

Auro Pharmacies Inc. DBA Central Drugs D-1082-2019
Class II · Moderate risk Terminated

Fayosim

Reason Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impurities) in Ethinyl Estradiol Tablets USP 0.01mg at 12 month long term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-860-11 D-1057-2019
Class II · Moderate risk Terminated

Gavilyte-N

Reason Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Lupin Somerset NDC 43386-050-19 D-1113-2019